Targeting TLR2 attenuates pulmonary inflammation and fibrosis by reversion of suppressive immune microenvironment.

Source:http://linkedlifedata.com/resource/pubmed/id/19109203

J. Immunol. 2009 Jan 1 182 1 692-702

Download in:

View as

General Info

PMID
19109203